CA Patent

CA2865316A1 — Agents useful for treating friedreich's ataxia and other neurodegenerative diseases

Assigned to IXCHEL PHARMA LLC · Expires 2012-11-01 · 14y expired

What this patent protects

This invention provides methods of identifying agents useful to prevent, ameliorate or treat one or more symptoms of Friedreich's ataxia or other neurodegenerative disease, and methods of employing the identified agents to prevent, reduce, delay or inhibit one or more symptoms of…

USPTO Abstract

This invention provides methods of identifying agents useful to prevent, ameliorate or treat one or more symptoms of Friedreich's ataxia or other neurodegenerative disease, and methods of employing the identified agents to prevent, reduce, delay or inhibit one or more symptoms of Friedreich's ataxia or other neurodegenerative disease.

Drugs covered by this patent

Patent Metadata

Patent number
CA2865316A1
Jurisdiction
CA
Classification
—
Expires
2012-11-01
Drug substance claim
No
Drug product claim
No
Assignee
IXCHEL PHARMA LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.